# Observational Neuromyelitis Optica studies: 24 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials that are observational for Neuromyelitis Optica that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Neuromyelitis Optica studies: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/neuromyelitis-optica

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 13, 2026 | NCT07762872 | A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD | Sponsor not shown (see the record) | Observational | Recruiting | Neuromyelitis Optica Spectrum Disorders (NMOSD) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762872) |
| July 15, 2026 | NCT07704294 | Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool | King's College London | Observational | Not yet recruiting | Optic Neuritis, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704294) |
| June 17, 2026 | NCT07653984 | Cohort Study on Neuroimmune Diseases in the Reproductive Age | Third Affiliated Hospital, Sun Yat-Sen University | Observational | Recruiting | Neuromyelitis Optica Spectrum Disorders (NMOSD), Multiple Sclerosis, Autoimmune Encephalitis, Myasthenia Gravis... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653984) |
| April 13, 2026 | NCT07526298 | Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable... | IRCCS San Raffaele | Observational | Not yet recruiting | Neuromyelitis Optica Spectrum Disorders | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526298) |
| January 12, 2026 | NCT07333196 | Tongji NADs Cohort | Tongji Hospital | Observational | Not yet recruiting | Multiple Sclerosis, NMO Spectrum Disorder, Autoimmune Encephalitis, Myelin Oligodendrocyte Glycoprotein... | 1,550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333196) |
| December 26, 2025 | NCT07304960 | Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder | Assiut University | Observational | Not yet recruiting | MS (Multiple Sclerosis), NMO Spectrum Disorder (NMOSD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07304960) |
| October 1, 2025 | NCT07202494 | Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration... | Assistance Publique Hopitaux De Marseille | Observational | Recruiting | Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody-Associated... | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07202494) |
| April 24, 2025 | NCT06941584 | Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | AIRE Deficiency | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06941584) |
| March 20, 2025 | NCT06885957 | Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD | Tongji Hospital | Observational | Recruiting | NMO Spectrum Disorder | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885957) |
| February 17, 2025 | NCT06829524 | HANDLE-a Real World Study on Satralizumab in NMOSD | Huashan Hospital | Observational | Recruiting | Neuromyelitis Optica Spectrum Disorders (NMOSD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06829524) |
| August 7, 2024 | NCT06541626 | Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Recruiting | Multiple Sclerosis, MS, Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein... | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06541626) |
| July 15, 2024 | NCT06502015 | Biomarkers in Autoimmune Disease of Nervous System | Tongji Hospital | Observational | Recruiting | Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis, Guillain-Barre... | 50,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06502015) |
| May 3, 2024 | NCT06398158 | Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder | University of Texas Southwestern Medical Center | Observational | Recruiting | Neuromyelitis Optica | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06398158) |
| March 15, 2024 | NCT06312644 | Study of Ultomiris® (Ravulizumab) Safety in Pregnancy | Alexion Pharmaceuticals, Inc. | Observational | Recruiting | Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic... | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06312644) |
| February 28, 2024 | NCT06280755 | Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. | icometrix | Observational | Recruiting | Multiple Sclerosis, NMO Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease... | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06280755) |
| August 9, 2023 | NCT05982925 | Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders | Icahn School of Medicine at Mount Sinai | Observational | Recruiting | Multiple Sclerosis, Neuromyelitis Optica, Demyelinating Autoimmune Diseases, CNS | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05982925) |
| July 28, 2023 | NCT05966467 | Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies | Alexion Pharmaceuticals, Inc. | Observational | Recruiting | Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05966467) |
| June 18, 2023 | NCT05909761 | Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy | Amgen | Observational | Recruiting | Neuromyelitis Optica Spectrum Disorder, Pregnancy Related | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05909761) |
| June 13, 2022 | NCT05415579 | Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM) | Dongzhimen Hospital, Beijing | Observational | Not yet recruiting | Demyelinating Diseases of the Central Nervous System (DDC) | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05415579) |
| January 24, 2022 | NCT05204459 | MS-ResearchBiomarkerS | Cedars-Sinai Medical Center | Observational | Recruiting | Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05204459) |
| August 23, 2021 | NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | University of Bern | Observational | Recruiting | Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis, Multiple Sclerosis, Neuromyelitis Optica... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05017142) |
| August 13, 2021 | NCT05004493 | Biorepository and Registry for Plasma Exchange Patients | Sponsor not shown (see the record) | Observational | Recruiting | Antibody-mediated Rejection, NMO Spectrum Disorder, TTP, CIDP | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05004493) |
| September 27, 2019 | NCT04106830 | Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE) | Beijing Tiantan Hospital | Observational | Recruiting | NMO Spectrum Disorder, MRI, Multiple Sclerosis, MOGAD | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04106830) |
| April 2, 2019 | NCT03900221 | French Registry for Monitoring Pregnancies for Multiple Sclerosis | Hospices Civils de Lyon | Observational | Recruiting | Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related... | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03900221) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Tongji Hospital | 3 |
| [Alexion Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/alexion-pharmaceuticals-inc) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| Assiut University | 1 |
| Beijing Tiantan Hospital | 1 |
| University of Bern | 1 |
| icometrix | 1 |
| Third Affiliated Hospital, Sun Yat-Sen University | 1 |
| Dongzhimen Hospital, Beijing | 1 |
| Cedars-Sinai Medical Center | 1 |
| Hospices Civils de Lyon | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| King's College London | 1 |
| IRCCS San Raffaele | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Huashan Hospital | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 9 |
| United States | 7 |
| Italy | 4 |
| Germany | 3 |
| France | 3 |
| South Korea | 2 |
| United Kingdom | 2 |
| Switzerland | 1 |
| Argentina | 1 |
| Canada | 1 |
| Japan | 1 |
| Czechia | 1 |
| Martinique | 1 |
| Australia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Radiology practices in the United States](https://specstream.ai/data/businesses/radiology-practices/united-states)
- [Gardening services in the United States](https://specstream.ai/data/businesses/gardening-services/united-states)
- [Assisted living facilities in the United States](https://specstream.ai/data/businesses/assisted-living-facilities/united-states)
- [Pediatric dentistry practices in the United States](https://specstream.ai/data/businesses/pediatric-dentistry-practices/united-states)
- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
